Cargando…

Neoadjuvant immunotherapy in breast cancer: a paradigm shift?

Despite advances in clinical management, a proportion of patients with early-stage triple-negative breast cancer (TNBC) recur after local treatment. The concept of neoadjuvant systemic therapy has been widely adopted to improve clinical outcomes of patients with TNBC and other breast tumour types. R...

Descripción completa

Detalles Bibliográficos
Autores principales: Fountzila, Elena, Ignatiadis, Michail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864681/
https://www.ncbi.nlm.nih.gov/pubmed/33574892
http://dx.doi.org/10.3332/ecancer.2020.1147